Also, overexpression of HER2/neu in HER2-negative breast cancer cells resulted in resistance to anti-cancer radiation therapy via the activation of signaling pathways that involve NF-κB signaling (Cao et al. 2009). The gene discussed is ERBB2; the disease is cancer.